Sodium potassium phosphate (combination preparation)

Generic name
Sodium potassium phosphate (combination preparation)
Brand name
ATC Code
B05XA06
Compare …

Sodium potassium phosphate (combination preparation)

Dosages
Side effects in children
Warnings & precautions in children
Contra-indications in children

Interactions
PK
Renal impairment
References

Pharmacokinetics in children

No information

dose recommendation of formulary compared to licensed use (on-label versus off-label)

No information is present at this moment.

Available formulations

No information is present at this moment.

Dosages

Maintenance requirement for phosphate in TPN
  • Intravenous
    • < 2 kg
      • From the fifth day of life: 1.2 mmol/kg/day, continuous infusion.
        • = 0.8 ml/kg/day at a phosphate concentration of 1.5 mmol/ml
        • Dose depending on plasma concentration.
        • Do not administer undiluted as a bolus. Be aware of the potential for arrhythmia when infused too fast: the maximum administration rate is 0.05 mmol phosphate/kg/hour, with an injection pump.

         No clinical studies have been carried out into the use of potassium sodium phosphate in children.

    • 2 up to 7 kg
      • From the fifth day of life: 0.75 mmol/kg/day, continuous infusion.
        • = 0.5 ml/kg/day at a phosphate concentration of 1.5 mmol/ml
        • Dose depending on plasma concentration.
        • Do not administer undiluted as a bolus. Be aware of the potential for arrhythmia when infused too fast: the maximum administration rate is 0.05 mmol phosphate/kg/hour, with an injection pump

        No clinical studies have been carried out into the use of potassium sodium phosphate in children.

         

    • 7 up to 30 kg
      • 0.65 mmol/kg/day, continuous infusion.
        • = 0.4 ml/kg/day at a phosphate concentration of 1.5 mmol/ml
        • Dose depending on plasma concentration.
        • Do not administer undiluted as a bolus. Be aware of the potential for arrhythmia when infused too fast: the maximum administration rate is 0.05 mmol phosphate/kg/hour, with an injection pump.

        No clinical studies have been carried out into the use of potassium sodium phosphate in children.

    • 30 up to 50 kg
      • 0.5 mmol/kg/day, continuous infusion.
        • = 0.3 ml/kg/day at a phosphate concentration of 1.5 mmol/ml
        • Dose depending on plasma concentration.
        • Do not administer undiluted as a bolus. Be aware of the potential for arrhythmia when infused too fast: the maximum administration rate is 0.05 mmol phosphate/kg/hour, with an injection pump.

        No clinical studies have been carried out into the use of potassium sodium phosphate in children.

Renal impaiment in children > 3 months

No information available on dose adjustment in renal impairment.

The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here

Side effects

No information is present at this moment.

The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here

Contra-indications

No information available on specific contra indications in children.

The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here

Warnings & precautions in children

Do not administer undiluted as a bolus. Be aware of the potential for arrhythmia when infused too fast: the maximum administration rate is 0.05 mmol phosphate/kg/hour, with an injection pump. Be aware of the possibility of a reaction with calcium

Interactions

The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here

Reference

  1. Rademaker C.M.A. et al, Geneesmiddelen-Formularium voor Kinderen, 2007

Changes

Therapeutic Drug Monitoring


Overdose